https://www.selleckchem.com/pr....oducts/vorapaxar.htm
In response to rising numbers of opioid overdose deaths, primary care providers have been called on to play a greater role in delivering buprenorphine treatment for opioid use disorder. However, policy makers and providers have raised concerns that expanding treatment access may reduce treatment quality and that primary care providers are not well equipped to deliver buprenorphine treatment. We investigated two research questions in response to these concerns How did buprenorphine treatment use and quality change in North Carolina Med
Like
Comment
Share
